|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.58 USD | -0.65% |
|
-5.95% | -23.54% |
BioCryst Pharmaceuticals, Inc. reported earnings results for the fourth quarter ended December 31, 2021. For the fourth quarter, the company reported revenue was USD 47.16 million compared to USD 4.02 million a year ago. Net loss was USD 17.78 million compared to USD 60.49 million a year ago.
Basic loss per share from continuing operations was USD 0.1 compared to USD 0.34 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -23.54% | 944M | |
| -3.39% | 102B | |
| +2.61% | 96.84B | |
| -0.76% | 21.48B | |
| -18.14% | 20.82B | |
| -7.31% | 18.6B | |
| -40.70% | 16.81B | |
| -26.89% | 13.78B | |
| +1.12% | 13.4B | |
| +22.25% | 11.06B |
BIOCRYST PHARMACEUTICALS, INC. 
